BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16979581)

  • 1. A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome.
    Blanchard EB; Lackner JM; Sanders K; Krasner S; Keefer L; Payne A; Gudleski GD; Katz L; Rowell D; Sykes M; Kuhn E; Gusmano R; Carosella AM; Firth R; Dulgar-Tulloch L
    Behav Res Ther; 2007 Apr; 45(4):633-48. PubMed ID: 16979581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome.
    Boyce PM; Talley NJ; Balaam B; Koloski NA; Truman G
    Am J Gastroenterol; 2003 Oct; 98(10):2209-18. PubMed ID: 14572570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care.
    Moss-Morris R; McAlpine L; Didsbury LP; Spence MJ
    Psychol Med; 2010 Jan; 40(1):85-94. PubMed ID: 19531276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial.
    Ljótsson B; Falk L; Vesterlund AW; Hedman E; Lindfors P; Rück C; Hursti T; Andréewitch S; Jansson L; Lindefors N; Andersson G
    Behav Res Ther; 2010 Jun; 48(6):531-9. PubMed ID: 20362976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom management for irritable bowel syndrome: a pilot randomized controlled trial of acupuncture/moxibustion.
    Anastasi JK; McMahon DJ; Kim GH
    Gastroenterol Nurs; 2009; 32(4):243-55. PubMed ID: 19696601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study of a self-administered treatment for irritable bowel syndrome: comparison to a wait list control group.
    Sanders KA; Blanchard EB; Sykes MA
    Appl Psychophysiol Biofeedback; 2007 Jun; 32(2):111-9. PubMed ID: 17564825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement.
    Whitehead WE; Palsson OS; Levy RL; Feld AD; VonKorff M; Turner M
    Am J Gastroenterol; 2006 May; 101(5):1057-65. PubMed ID: 16573774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of irritable bowel syndrome with osteopathy: results of a randomized controlled pilot study.
    Hundscheid HW; Pepels MJ; Engels LG; Loffeld RJ
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1394-8. PubMed ID: 17716344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo.
    Enck P; Zimmermann K; Menke G; Klosterhalfen S
    Z Gastroenterol; 2009 Feb; 47(2):209-14. PubMed ID: 19197823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome.
    Gonsalkorale WM; Toner BB; Whorwell PJ
    J Psychosom Res; 2004 Mar; 56(3):271-8. PubMed ID: 15046962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
    Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
    Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome.
    Heymann-Mönnikes I; Arnold R; Florin I; Herda C; Melfsen S; Mönnikes H
    Am J Gastroenterol; 2000 Apr; 95(4):981-94. PubMed ID: 10763948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome--a randomized controlled trial with primary care physicians.
    Enck P; Zimmermann K; Menke G; Müller-Lissner S; Martens U; Klosterhalfen S
    Neurogastroenterol Motil; 2008 Oct; 20(10):1103-9. PubMed ID: 18565142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure and mindfulness based therapy for irritable bowel syndrome--an open pilot study.
    Ljótsson B; Andréewitch S; Hedman E; Rück C; Andersson G; Lindefors N
    J Behav Ther Exp Psychiatry; 2010 Sep; 41(3):185-90. PubMed ID: 20079485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
    Drossman DA; Danilewitz M; Naesdal J; Hwang C; Adler J; Silberg DG
    Am J Gastroenterol; 2008 Oct; 103(10):2562-9. PubMed ID: 18775020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial.
    Vlieger AM; Menko-Frankenhuis C; Wolfkamp SC; Tromp E; Benninga MA
    Gastroenterology; 2007 Nov; 133(5):1430-6. PubMed ID: 17919634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome.
    van der Veek PP; van Rood YR; Masclee AA
    Aliment Pharmacol Ther; 2007 Sep; 26(6):943-52. PubMed ID: 17767479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.